In vivo, we found that mice co-injected with OXTRHigh CAFs and HN6 tumor cells had a more significant tumor burden and increased metastasis to lymph nodes than OXTRHigh CAFs deficient in OXTR (Fig. 4h, i). This evidence concerns the gene OXTR and neoplasm.